Product correctly added to cart.

discount label
Felbamate Related Compound A
View 3D

Biosynth logo

Felbamate Related Compound A

CAS: 25451-53-0

Ref. 3D-ABA45153

1mg
310.00 €
2mg
436.00 €
5mg
582.00 €
10mg
801.00 €
25mg
1,392.00 €
Estimated delivery in United States, on Wednesday 15 Jan 2025

Product Information

Name:
Felbamate Related Compound A
Synonyms:
  • 1,3-Propanediol, 2-phenyl-, 1-carbamate
  • 2-Phenyl-1,3-propanediol monocarbamate
  • 1,3-Propanediol, 2-phenyl-, monocarbamate
  • 2-Phenyl-1,3-propanediyl monocarbamate
  • W 873
Description:

Felbamate Related Compound A is a metabolite of felbamate, a drug used in the treatment of epilepsy and some types of neuropathic pain. It has been shown to be active against cholinergic receptors, with significant cytotoxicity in human tumor cells. Felbamate Related Compound A has also been shown to be effective as an anti-inflammatory agent (potentiating the effects of corticosteroids) and for treating bladder cancer. The oral administration dose is about 10 mg/kg, which is approximately five times lower than the therapeutic dose for felbamate.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
195.22 g/mol
Formula:
C10H13NO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-ABA45153 Felbamate Related Compound A

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".